Table 2 |
|||||||
|
% FA from blood, synthesized de novo, and calculated incorporation of acetyl-CoA into de novo synthesized FA (ACE)1 |
|||||||
|
Day relative to parturition |
|||||||
|
|
|||||||
|
Item |
15 |
30 |
60 |
120 |
240 |
SEM |
P-Value2 |
|
|
|||||||
|
Synthesized FA %3 |
46.4a |
48.9ab |
53.5bc |
57.8c |
52.8abc |
2.08 |
< 0.01 |
|
FA from blood %4 |
53.6c |
51.1bc |
46.5ab |
42.2a |
47.2abc |
2.08 |
< 0.01 |
|
ACE mol/d5 |
5.2a |
14.0b |
13.8b |
12.9b |
12.0b |
1.46 |
< 0.01 |
|
ACE mol/d6 |
4.9a |
13.7b |
13.5b |
12.6b |
11.7b |
1.42 |
< 0.01 |
|
Δ9-Desaturase index7 |
0.35b |
0.33b |
0.30ab |
0.27a |
0.30ab |
0.17 |
< 0.01 |
|
|
|||||||
|
1 The complete FA datasets (mole/day and g/100 g) are reported in Additional file 1 (Tables S6 and S7). 2Effect of day. 3 Fatty acid with carbon length 4÷14 (except 11)/tot FA (except 16:0 and 16:1). 4 Fatty acid with carbon length >16 (included 11 and 15)/tot FA (except 16:0 and 16:1). 5 ACE corrected (Additional file 1, Table S6). 6ACE corrected without considering odd chain FA (11:0, 15:0) (Additional file 1, Table S6). 7 Overall Δ9 desaturase index, calculated from (14:1 c9 + 16:1 c9 + 18:1 c9 + 18:2 c9, t11)/(14:0 + 14:1 c9 + 16:0 + 16:1 c9 + 18:0 + 18:1 c9 + 18:1 t11 + 18:1 c9, t11) a,b,c denote P < 0.05 |
|||||||
|
Bionaz and Loor BMC Genomics 2008 9:366 doi:10.1186/1471-2164-9-366 |
|||||||